MIAMI, July 14, 2023 (GLOBE NEWSWIRE) — ASPN Annual Convention – Relievant Medsystems, an organization devoted to reworking the analysis and remedy of vertebrogenic low again ache, immediately introduced the discharge of next-generation Intracept® Entry Devices. The brand new devices provide extra predictable and exact concentrating on of the basivertebral nerve (BVN) in the course of the confirmed, sturdy, and secure Intracept® Process.
“We’re dedicated to continued innovation in assist of our physicians as we increase affected person remedy with the Intracept Process. Right this moment, we’re happy to announce the launch of a number of new devices providing higher management, precision, and ease of use in the course of the process,” mentioned Tyler Binney, President and CEO of Relievant Medsystems. “These next-generation Intracept Entry Devices are function constructed to reinforce BVN entry and procedural effectivity whereas persistently delivering optimistic outcomes.”
Greater than 10,000 sufferers have been handled with Relievant Medsystems’ minimally invasive Intracept Process, the one FDA-cleared remedy for persistent vertebrogenic low again ache. The identical-day outpatient process makes use of focused radiofrequency vitality to cease the BVN from transmitting ache alerts to the mind and takes roughly one hour to carry out.
The subsequent-generation Intracept Entry Devices are designed for predictable efficiency throughout a variety of bone densities and embody:
- Bevel and Diamond Introducers to allow constant entry with a depth marker for optimum positioning
- Curved Cannula Meeting with J-Stylet that permits for true steerability to create a predictable path to the BVN
- Straight Stylet to effectively lengthen or change entry path trajectory
- Along with these entry devices, the Intracept® RF Probe, which delivers focused radiofrequency vitality, now includes a versatile shaft to extend C-arm working clearance
“I’ve been performing the Intracept Process for greater than a decade and I’ve seen the profound influence it has on bettering sufferers’ lives,” mentioned Gregory Moore, MD, Co-Founder and Associate of Pacific Sports activities and Backbone. “The subsequent-generation Intracept Entry Devices elevate the bar by delivering much more predictable efficiency and empower physicians to extra readily entry and goal the BVN for lasting ache aid.”
The discharge of the next-generation Intracept Entry Devices was introduced on the Fifth Annual American Society of Ache and Neuroscience (ASPN) Convention happening July 13-16 in Miami. For extra info on the Intracept Entry Devices, go to: https://www.relievant.com/intracept/intracept-system/.
About Vertebrogenic Ache
Of the 30 million individuals within the U.S. with persistent low again ache, 1 in 6 are more likely to have vertebrogenic ache, a definite kind of persistent low again ache brought on by injury to vertebral endplates, the interface between the disc and the vertebral physique. Sufferers usually have ache in the course of their low again, which worsens after they bend over, sit for lengthy intervals of time, or when they’re energetic. A doctor can affirm a affected person’s ache is vertebrogenic by observing Modic adjustments, a biomarker seen on commonplace MRI that signifies irritation on the vertebral endplate.
About Relievant Medsystems
Relievant Medsystems is a commercial-stage medical machine firm reworking the analysis and remedy of vertebrogenic ache, a type of Power Low Again Ache (CLBP), with the Intracept Process – a novel, clinically confirmed and commercially out there remedy designed to enhance the standard of life for thousands and thousands of indicated sufferers. For extra details about Relievant Medsystems and the Intracept Process, go to www.relievant.com.
Shelli Lissick, Bellmont Companions
(651) 276-6922 | email@example.com
Marissa Bych, Gilmartin Group
(805) 305-1244 | firstname.lastname@example.org